ERBB2 and neoplasm: They also carry relevant clinical information about tumor-specific mutations in multiple genes such as epidermal growth factor receptor (EGFR), proto-oncogene B-Raf, RAS, isocitrate dehydrogenase 1 and human epidermal growth factor receptor 2 (HER2) [64].